Distribution of β-globin gene mutations in thalassemia minor population of kerman province, Iran

Iranian Journal of Public Health

Volumn 39, Issue 2, 2010, Pages 69-76

  Saleh Gohari, N ^a   Bazrafshani, M R ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Mutations; Globin gene; thalassemia

Indexed keywords

EID: 77954058615     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Carver MF, Hushiman TH (1996). International Hemoglobin Information Center variant list. Hemoglobin, 20 (3):213.
2. Flint J, Harding RM, Boyce AG, Clegg JB (1998). The population genetics of the hae-moglobinopathies. Baillieres Clin Haematol, 11(1): 1-51.
3. Cao A, Gossens M, Pirastu M (1989). β-thalassaemia mutations in Mediterranean populations. Br J Haematol, 71(3): 309-12.
4. Zahed L (2001). The spectrum of β-thalassaemia mutations in the Arab populations. J Biomed Biotechnol, 1(3):129-32.
5. Rahimi Z, Vaisi Raygani A, Merat A, Hagh-shenass M, Gerard N, Nagel RL, et al. (2006). Thalassemic mutation in southern Iran. IJMS, 31(2): 71-3.
6. Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Ghawidel-Parsa S, Naieni Kh, Rahmani M, et al. (2007). Distribution of beta-thalassemia mutations in the northern provinces of Iran. Hemoglobin, 31(3):351-56.
7. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, et al. (2001). The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin, 25(3): 285-96.
8. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16:1215-16.
9. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summeres C, Kalsheker N, et al. (1989). Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res, 17(7): 2503-16.
10. Yavarian M, Harteveled CL, Batelaan D, Bernini LF, Giordano PC (2001). Molecular spectrum of beta-thalassemia in the Iranian Province of Hormozgan. Hemoglobin, 25(1): 3543.
11. Miri Moghadam E, Narooie Nejad M, Eshgi P, Zeinali S, Savad koohi F (2005). Molecular basis and prenatal diagnosis of p-Thalassemia in southeast of Iran. Jornal of Mazanderan University of Medical Sciences, 48(15): 105-11.
12. Khan SN, Riazuddin S (1998). Molecular characterization of beta-thalassemia in Pakistan. Hemoglobin, 22(4): 333-45.
13. Al-Ali AK, Al-Ateeq S, Imamwerdi BW, Al-sowayan S, Al-Madan M, Al-Mu-hanna F, Bashaweri L, Qaw F (2005). Molecular Bases of beta-Thalassemia in the Eastern Province of Saudi Arabia. J Bio-medBiotechnol, (4): 322-25.
14. Yousefi MH (1997). Beta Thalassemia trait in Sanandaj. Scientific Journal of Kurde-stan University of Medical Sciences, 4(1): 11-3.
15. Khodaei H, Zeinali C, Delmaghani S (2001). Molecular studies on Beta-Thalassemia mutations in Bushehr province. Iranian South Medical Journal, 2(3): 89-3.
16. Kiani AA, Mortazavi Y, Zainali S, Shirkhani Y (2007). The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran. Hemoglobin, 31(3): 343-49.
17. Mohaddess Ardabili SM, Jabbarzadeh Tabrizi S, Nikan Far AR, Rahbani Nobar M (2004). Prevalent mutations of Beta-globin gene at the central part of east Azerbaijan, Iran. Medical Journal of Tabriz University of Medical Sciences & health Services, 62: 72-67
18. Omrani MD (2003). Finding the most prevalent?-Thalassemia mutations in west Azerbaijan province using ARMS/PCR method. Urmia Medical Journal, 2(14): 126-17.
19. Modjtahed Zadeh F (1999). Beta Thalassemia gene mutations in Thalassemic patients referred to Boo Ali Sina Hospital of Sari the year 1373. Journal of Mazanderan University of Medical Sciences, 23-22(9): 37-2.